Liver metastases from gastric carcinoma

Report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2)

L. Fabbri, R. Ridolfi, A. Riccobon, R. Maltoni, E. Flamini, R. Fedriga, A. Flamigni, G. Migliori, F. Ortolani, F. Calzolari, D. Amadori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A 37-year-old patient with liver metastases from gastric cancer was treated with a double adoptive immunotherapy regimen comprising tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2 because of an extremely high in vitro cytotoxic specific activity on established gastric cancer cell lines. The necrosis verified in the center of the hepatic metastasis would appear to demonstrate treatment efficacy, but no clinical response was seen. In vitro cytotoxicity data alone are insufficient to predict the clinical efficacy of adoptive immunotherapy.

Original languageEnglish
Pages (from-to)445-449
Number of pages5
JournalTumori
Volume81
Issue number6
Publication statusPublished - 1995

Fingerprint

Tumor-Infiltrating Lymphocytes
Adoptive Immunotherapy
Lymphokine-Activated Killer Cells
Stomach Neoplasms
Interleukin-2
Stomach
Neoplasm Metastasis
Carcinoma
Liver
Necrosis
Cell Line
In Vitro Techniques

Keywords

  • gastric cancer
  • interleukin-2
  • lymphokine-activated killer cells
  • tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Liver metastases from gastric carcinoma : Report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2). / Fabbri, L.; Ridolfi, R.; Riccobon, A.; Maltoni, R.; Flamini, E.; Fedriga, R.; Flamigni, A.; Migliori, G.; Ortolani, F.; Calzolari, F.; Amadori, D.

In: Tumori, Vol. 81, No. 6, 1995, p. 445-449.

Research output: Contribution to journalArticle

Fabbri, L. ; Ridolfi, R. ; Riccobon, A. ; Maltoni, R. ; Flamini, E. ; Fedriga, R. ; Flamigni, A. ; Migliori, G. ; Ortolani, F. ; Calzolari, F. ; Amadori, D. / Liver metastases from gastric carcinoma : Report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2). In: Tumori. 1995 ; Vol. 81, No. 6. pp. 445-449.
@article{14a4fdd1603c40bf95656374447b3070,
title = "Liver metastases from gastric carcinoma: Report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2)",
abstract = "A 37-year-old patient with liver metastases from gastric cancer was treated with a double adoptive immunotherapy regimen comprising tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2 because of an extremely high in vitro cytotoxic specific activity on established gastric cancer cell lines. The necrosis verified in the center of the hepatic metastasis would appear to demonstrate treatment efficacy, but no clinical response was seen. In vitro cytotoxicity data alone are insufficient to predict the clinical efficacy of adoptive immunotherapy.",
keywords = "gastric cancer, interleukin-2, lymphokine-activated killer cells, tumor-infiltrating lymphocytes",
author = "L. Fabbri and R. Ridolfi and A. Riccobon and R. Maltoni and E. Flamini and R. Fedriga and A. Flamigni and G. Migliori and F. Ortolani and F. Calzolari and D. Amadori",
year = "1995",
language = "English",
volume = "81",
pages = "445--449",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Liver metastases from gastric carcinoma

T2 - Report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2)

AU - Fabbri, L.

AU - Ridolfi, R.

AU - Riccobon, A.

AU - Maltoni, R.

AU - Flamini, E.

AU - Fedriga, R.

AU - Flamigni, A.

AU - Migliori, G.

AU - Ortolani, F.

AU - Calzolari, F.

AU - Amadori, D.

PY - 1995

Y1 - 1995

N2 - A 37-year-old patient with liver metastases from gastric cancer was treated with a double adoptive immunotherapy regimen comprising tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2 because of an extremely high in vitro cytotoxic specific activity on established gastric cancer cell lines. The necrosis verified in the center of the hepatic metastasis would appear to demonstrate treatment efficacy, but no clinical response was seen. In vitro cytotoxicity data alone are insufficient to predict the clinical efficacy of adoptive immunotherapy.

AB - A 37-year-old patient with liver metastases from gastric cancer was treated with a double adoptive immunotherapy regimen comprising tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2 because of an extremely high in vitro cytotoxic specific activity on established gastric cancer cell lines. The necrosis verified in the center of the hepatic metastasis would appear to demonstrate treatment efficacy, but no clinical response was seen. In vitro cytotoxicity data alone are insufficient to predict the clinical efficacy of adoptive immunotherapy.

KW - gastric cancer

KW - interleukin-2

KW - lymphokine-activated killer cells

KW - tumor-infiltrating lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0029555981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029555981&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 445

EP - 449

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -